Kyunghee Institute

Shingles Vaccine Reduces Cardiovascular Risk by 23% for Up to Eight Years, Study Finds

15 days ago

• A large-scale study of over 1.2 million people found that receiving a shingles vaccine is associated with a 23% lower risk of cardiovascular events, with protection lasting up to eight years. • The protective effect was strongest in men, individuals under 60, and those with unhealthy lifestyles, with a 26% reduction in major cardiovascular events including stroke, heart attack, and death from heart disease. • Researchers suggest the vaccine may prevent cardiovascular complications by reducing shingles-related blood vessel damage, inflammation, and clot formation that can contribute to heart disease.